Shukun, a Chinese start-up that develops artificial intelligence (AI) technology used in the diagnosis of cardiovascular diseases, has raised RMB200 million ($28 million) in an extended Series B round led by BOC International and CCB International.
Existing investors China Creation Ventures (CCV) and Huagai Capital re-upped. CCV led the first tranche of the Series B - also worth RMB200 million - in February 2019. This followed a Series A round...
Singapore’s Openspace Ventures has hired Jessica Huang Pouleur (pictured), formerly of Providence Equity Partners and latterly head of Asia M&A for The Walt Disney Company, as an executive director.
The Blackstone Group has made a partial exit from Indian packaging manufacturer Essel Propack (EPL) – which provides the tubes to 40% of the world’s toothpaste – generating proceeds of INR18.6 billion ($253.4 million).
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.